1. Adjuvants: Classification,Modus Operandi, and Licensing
    Juliana de Souza Apostólico et al, 2016, Journal of Immunology Research CrossRef
  2. Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro
    Fucai Wang et al, 2017 CrossRef
  3. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils
    Le Guo et al, 2017, Helicobacter CrossRef
  4. DNA vaccines against leptospirosis: A literature review
    Marcelle Moura Silveira et al, 2017, Vaccine CrossRef
  5. Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases
    Bijay Singh et al, 2017, International Journal of Biological Macromolecules CrossRef
  6. Effects of Chitosan and Chitosan N-Acetylcysteine Solutions on Conjunctival Epithelial Cells
    Nadine Schuerer et al, 2018, Journal of EuCornea CrossRef
  7. Future of Helicobacter pylori and its feasibility
    Amin Talebi Bezmin Abadi et al, 2018, Expert Review of Anti-infective Therapy CrossRef
  8. Needle-Free Immunization with Chitosan-Based Systems
    Bijay Singh et al, 2018, IJMS CrossRef
  9. Crosstalk between chitosan and cell signaling pathways
    Behrouz Farhadihosseinabadi et al, 2019, Cell. Mol. Life Sci. CrossRef
  10. Therapeutic Protection Against H. pylori Infection in Mongolian Gerbils by Oral Immunization With a Tetravalent Epitope-Based Vaccine With Polysaccharide Adjuvant
    Le Guo et al, 2019, Front. Immunol. CrossRef
  11. null
    Carla Harkin et al, 2019 CrossRef
  12. Inflammation, immunity, and vaccines forHelicobacter pyloriinfection
    Dominique Velin et al, 2016, Helicobacter CrossRef
  13. Mucosal vaccines: Strategies and challenges
    Miao Li et al, 2019, Immunology Letters CrossRef
  14. Chitosan: a compound for drug delivery system in gastric cancer-a review
    Rana Shafabakhsh et al, 2020, Carbohydrate Polymers CrossRef
  15. Chitosan-adjuvanted Salmonella subunit nanoparticle vaccine for poultry delivered through drinking water and feed
    Sankar Renu et al, 2020, Carbohydrate Polymers CrossRef
  16. Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
    Zifan Song et al, 2020, Front. Microbiol. CrossRef
  17. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice
    Patrícia C. Henriques et al, 2020, Acta Biomaterialia CrossRef
  18. Optimally Fabricated Chitosan Particles Containing Ovalbumin Induced Cellular and Humoral Immunity in Immunized Mice
    Seung Hoon Kim et al, 2020, Biotechnol Bioproc E CrossRef
  19. A Review of Biodegradable Natural Polymer-Based Nanoparticles for Drug Delivery Applications
    Humaira Idrees et al, 2020, Nanomaterials CrossRef
  20. Chitosan Inhibits Helicobacter pylori Growth and Urease Production and Prevents Its Infection of Human Gastric Carcinoma Cells
    Shun-Hsien Chang et al, 2020, Marine Drugs CrossRef
  21. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori
    Jo‐Lewis Banga Ndzouboukou et al, 2020, Helicobacter CrossRef
  22. Iron nanoparticles as novel vaccine adjuvants
    Maryam Behzadi et al, 2021, European Journal of Pharmaceutical Sciences CrossRef
  23. Alginate-chitosan microcapsules improve vaccine potential of gamma-irradiated Listeria monocytogenes against listeriosis in murine model
    Cláudia E.V. Rocha et al, 2021, International Journal of Biological Macromolecules CrossRef
  24. Preparation of novel poly(vinyl alcohol)/chitosan lactate-based phase-separated composite films for UV-shielding and drug delivery applications
    Dilshad Qureshi et al, 2021, Polym. Bull. CrossRef
  25. Recent advances on chitosan as an adjuvant for vaccine delivery
    Isra Dmour et al, 2021, International Journal of Biological Macromolecules CrossRef
  26. Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection
    Majid T. Moghadam et al, 2021, CPB CrossRef
  27. Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy
    Heping Lian et al, 2022, Pharmaceutics CrossRef
  28. A multifunctional chitosan-based hydrogel with self-healing, antibacterial, and immunomodulatory effects as wound dressing
    Qing Yu et al, 2023, International Journal of Biological Macromolecules CrossRef
  29. In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli
    Maryam Rezaei et al, 2023, International Immunopharmacology CrossRef
  30. Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice
    Qiong Liu et al, 2023, Infect Immun CrossRef
  31. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review
    Kuang Yunle et al, 2023, Helicobacter CrossRef
  32. Adjuvant properties of chitosan derivatives administered to mice with anti-rabies vaccine
    K. B. Dobroskok et al, 2024, Veterinariâ segodnâ CrossRef
  33. Animal Models of Helicobacter pylori Infection and Vaccines: Current Status and Future Prospects
    Zhili Liu et al, 2024, Helicobacter CrossRef